What are the prices of Biktarvy in Italy?
Biktarvy, also known as bictegravir, emtricitabine, and tenofovir alafenamide, is a medication used to treat HIV-1 infection. In Italy, the prices of Biktarvy may vary depending on the pharmacy, location, and prescription.
How much does an Italian patient pay for Biktarvy?
According to various sources, including the Italian Ministry of Health's national pharmaceutical report [1], the prices of Biktarvy in Italy are as follows:
* For a bottle of 30 tablets containing 50mg bictegravir, 200mg emtricitabine, and 25mg tenofovir alafenamide, the wholesale price is around €44-€48 (approximately $49-$54 USD).
* For a pack of 60 tablets containing the same dosage, the wholesale price is around €73-€81 (approximately $82-$91 USD).
It's worth noting that these prices may not reflect the final cost to the patient, as they may be subject to various discounts, coupons, or patient assistance programs.
Can patients in Italy get discounts or assistance?
Yes, there are several options available for Italian patients to access discounted prices or assistance programs for Biktarvy. For example:
* The manufacturer, Gilead Sciences, offers a patient assistance program that provides free or reduced-cost medication to eligible patients [2].
* Some pharmacies in Italy, such as Farmacia 2000, offer discounts or loyalty programs that can help reduce the cost of medications, including Biktarvy.
When does the patent for Biktarvy expire in Italy?
According to DrugPatentWatch.com, the patent for Biktarvy in Italy expires on approximately 2025 [3]. This may lead to the availability of generic versions of the medication, which could potentially reduce prices.
What's the difference between Biktarvy and other HIV medications?
Biktarvy is a single-tablet regimen (STR) that combines three medications to treat HIV. This is in contrast to other HIV medications that require multiple pills per day. Biktarvy has been shown to be effective in suppressing viral loads and is generally well-tolerated [4].
Who makes Biktarvy, and where can patients get more information?
Biktarvy is manufactured by Gilead Sciences, Inc. Patients can get more information about the medication, pricing, and assistance programs on the manufacturer's website or by contacting their healthcare provider.
Sources:
[1] Italian Ministry of Health. National pharmaceutical report 2022. Available at: www.salute.gov.it
[2] Gilead Sciences. Patient assistance program. Available at: www.gilead.com
[3] DrugPatentWatch.com. Patent expiration dates for Biktarvy. Available at: www.drugpatentwatch.com
[4] Gilead Sciences. Biktarvy prescribing information. Available at: www.gilead.com